Cargando…

Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients

BACKGROUND: Cholesterol gallstone disease (GS) is highly prevalent among Hispanics and American Indians. In GS, the pool of bile acids (BA) is decreased, suggesting that BA absorption is impaired. In Caucasian GS patients, mRNA levels for ileal BA transporters are decreased. We aimed to determine fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera, Jorge, Amigo, Ludwig, Husche, Constanze, Benítez, Carlos, Zanlungo, Silvana, Lütjohann, Dieter, Miquel, Juan Francisco, Nervi, Flavio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797496/
https://www.ncbi.nlm.nih.gov/pubmed/19995447
http://dx.doi.org/10.1186/1476-511X-8-53
_version_ 1782175627183390720
author Herrera, Jorge
Amigo, Ludwig
Husche, Constanze
Benítez, Carlos
Zanlungo, Silvana
Lütjohann, Dieter
Miquel, Juan Francisco
Nervi, Flavio
author_facet Herrera, Jorge
Amigo, Ludwig
Husche, Constanze
Benítez, Carlos
Zanlungo, Silvana
Lütjohann, Dieter
Miquel, Juan Francisco
Nervi, Flavio
author_sort Herrera, Jorge
collection PubMed
description BACKGROUND: Cholesterol gallstone disease (GS) is highly prevalent among Hispanics and American Indians. In GS, the pool of bile acids (BA) is decreased, suggesting that BA absorption is impaired. In Caucasian GS patients, mRNA levels for ileal BA transporters are decreased. We aimed to determine fecal BA excretion rates, mRNA levels for ileal BA transporter genes and of regulatory genes of BA synthesis in Hispanic GS patients. RESULTS: Excretion of fecal BA was measured in seven GS females and in ten GS-free individuals, all with a body mass index < 29. Participants ingested the stool marker Cr(2)O(3 )(300 mg/day) for 10 days, and fecal specimens were collected on the last 3 days. Chromium was measured by a colorimetric method, and BA was quantitated by gas chromatography/mass spectroscopy. Intake of calories, nutrients, fiber and cholesterol were similar in the GS and GS-free subjects. Mean BA excretion levels were 520 ± 80 mg/day for the GS-free group, and 461 ± 105 mg/day for the GS group. Messenger RNA expression levels were determined by RT-PCR on biopsy samples obtained from ileum during diagnostic colonoscopy (14 GS-free controls and 16 GS patients) and from liver during surgery performed at 8 and 10 AM (12 GS and 10 GS-free patients operated on for gastrointestinal malignancies), all with a body mass index < 29. Messenger RNA level of the BA transporter genes for ileal lipid binding protein, multidrug resistance-associated protein 3, organic solute transporter alpha, and organic solute transporter beta were similar in GS and GS-free subjects. Messenger RNA level of Cyp27A1, encoding the enzyme 27α-hydroxylase, the short heterodimer partner and farnesoid X receptor remained unchanged, whereas the mRNA level of Cyp7A1, the rate limiting step of BA synthesis, was increased more than 400% (p < 0.01) in the liver of GS compared to GS-free subjects. CONCLUSION: Hispanics with GS have fecal BA excretion rates and mRNA levels of genes for ileal BA transporters that are similar to GS-free subjects. However, mRNA expression levels of Cyp7A1 are increased in GS, indicating that regulation of BA synthesis is abnormal in Hispanics with GS.
format Text
id pubmed-2797496
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27974962009-12-24 Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients Herrera, Jorge Amigo, Ludwig Husche, Constanze Benítez, Carlos Zanlungo, Silvana Lütjohann, Dieter Miquel, Juan Francisco Nervi, Flavio Lipids Health Dis Research BACKGROUND: Cholesterol gallstone disease (GS) is highly prevalent among Hispanics and American Indians. In GS, the pool of bile acids (BA) is decreased, suggesting that BA absorption is impaired. In Caucasian GS patients, mRNA levels for ileal BA transporters are decreased. We aimed to determine fecal BA excretion rates, mRNA levels for ileal BA transporter genes and of regulatory genes of BA synthesis in Hispanic GS patients. RESULTS: Excretion of fecal BA was measured in seven GS females and in ten GS-free individuals, all with a body mass index < 29. Participants ingested the stool marker Cr(2)O(3 )(300 mg/day) for 10 days, and fecal specimens were collected on the last 3 days. Chromium was measured by a colorimetric method, and BA was quantitated by gas chromatography/mass spectroscopy. Intake of calories, nutrients, fiber and cholesterol were similar in the GS and GS-free subjects. Mean BA excretion levels were 520 ± 80 mg/day for the GS-free group, and 461 ± 105 mg/day for the GS group. Messenger RNA expression levels were determined by RT-PCR on biopsy samples obtained from ileum during diagnostic colonoscopy (14 GS-free controls and 16 GS patients) and from liver during surgery performed at 8 and 10 AM (12 GS and 10 GS-free patients operated on for gastrointestinal malignancies), all with a body mass index < 29. Messenger RNA level of the BA transporter genes for ileal lipid binding protein, multidrug resistance-associated protein 3, organic solute transporter alpha, and organic solute transporter beta were similar in GS and GS-free subjects. Messenger RNA level of Cyp27A1, encoding the enzyme 27α-hydroxylase, the short heterodimer partner and farnesoid X receptor remained unchanged, whereas the mRNA level of Cyp7A1, the rate limiting step of BA synthesis, was increased more than 400% (p < 0.01) in the liver of GS compared to GS-free subjects. CONCLUSION: Hispanics with GS have fecal BA excretion rates and mRNA levels of genes for ileal BA transporters that are similar to GS-free subjects. However, mRNA expression levels of Cyp7A1 are increased in GS, indicating that regulation of BA synthesis is abnormal in Hispanics with GS. BioMed Central 2009-12-08 /pmc/articles/PMC2797496/ /pubmed/19995447 http://dx.doi.org/10.1186/1476-511X-8-53 Text en Copyright ©2009 Herrera et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Herrera, Jorge
Amigo, Ludwig
Husche, Constanze
Benítez, Carlos
Zanlungo, Silvana
Lütjohann, Dieter
Miquel, Juan Francisco
Nervi, Flavio
Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients
title Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients
title_full Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients
title_fullStr Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients
title_full_unstemmed Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients
title_short Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients
title_sort fecal bile acid excretion and messenger rna expression levels of ileal transporters in high risk gallstone patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797496/
https://www.ncbi.nlm.nih.gov/pubmed/19995447
http://dx.doi.org/10.1186/1476-511X-8-53
work_keys_str_mv AT herrerajorge fecalbileacidexcretionandmessengerrnaexpressionlevelsofilealtransportersinhighriskgallstonepatients
AT amigoludwig fecalbileacidexcretionandmessengerrnaexpressionlevelsofilealtransportersinhighriskgallstonepatients
AT huscheconstanze fecalbileacidexcretionandmessengerrnaexpressionlevelsofilealtransportersinhighriskgallstonepatients
AT benitezcarlos fecalbileacidexcretionandmessengerrnaexpressionlevelsofilealtransportersinhighriskgallstonepatients
AT zanlungosilvana fecalbileacidexcretionandmessengerrnaexpressionlevelsofilealtransportersinhighriskgallstonepatients
AT lutjohanndieter fecalbileacidexcretionandmessengerrnaexpressionlevelsofilealtransportersinhighriskgallstonepatients
AT miqueljuanfrancisco fecalbileacidexcretionandmessengerrnaexpressionlevelsofilealtransportersinhighriskgallstonepatients
AT nerviflavio fecalbileacidexcretionandmessengerrnaexpressionlevelsofilealtransportersinhighriskgallstonepatients